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ORIGINAL STUDIES
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Abstract
Background: The optimal access site for cardiac catheterization in patients with prior
coronary artery bypass surgery (CABG) continues to be debated.
Methods: We performed a random effects frequentist and Bayesian meta-analysis of
4 randomized trials and 18 observational studies, including 60,192 patients with prior
CABG (27,236 in the radial group; 32,956 in the femoral group) that underwent cardiac catheterization. Outcomes included (1) access-site complications, (2) crossover
to a different vascular access, (3) procedure time, and (4) contrast volume. Mean differences (MD) and 95% confidence interval (CI) were calculated for continuous outcomes and odds ratios (OR) and 95% CI for binary outcomes.
Results: Among randomized trials, crossover (OR: 7.63; 95% CI: 2.04, 28.51;

University of Nebraska Medical Center,
Omaha, Nebraska, USA

p = 0.003) was higher in the radial group, while access site complications (OR: 0.96;
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95% CI: 0.34, 2.87; p = 0.94) and contrast volume (MD: 15.08; 95% CI:
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higher (OR: 5.09; 95% CI: 2.43, 10.65; p < 0.001), while access site complication rates

10.19,

40.35; p = 0.24) were similar. Among observational studies, crossover rates were
(OR: 0.52; 95% CI: 0.30, 0.89; p = 0.02) and contrast volume (MD:
13.14,

7.52; 95% CI:

1.90 ml; p = 0.009) were lower in the radial group. Bayesian analysis

suggested that the odds of a difference existing between radial and femoral are small
for all endpoints except crossover to another access site.
Conclusion: In a frequentist and Bayesian meta-analysis of patients with prior CABG
undergoing coronary catheterization, radial access was associated with lower incidence of vascular access complications and lower contrast volume but also higher
crossover rate.
KEYWORDS

catheterization brachial/radial/ulnar, complications, coronary bypass grafts, meta-analysis,
percutaneous coronary intervention (PCI), vascular access
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I N T RO DU CT I O N
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2.2

|

Study definitions

The preferred vascular access site for cardiac catheterization in

Access-site complications were adjudicated according to the defini-

patients with prior coronary artery bypass surgery (CABG) continues

tions used by each study; when not clearly defined in Section 2, the

to be debated.1 Randomized data are conflicting, with one study

following events were adjudicated: access-site hematoma, access site

showing greater contrast and radiation dose and longer procedure

related bleeding, pseudoaneurysm, arteriovenous fistula, retroperito-

2

time with radial access, and another showing non-inferiority of radial

neal bleeding, arterial dissection or occlusion, arterial spasm and limb

compared with femoral.3 Observational studies have suggested that

ischemia. Two authors (Ilias Nikolakopoulos and Evangelia Vemmou)

use of radial access may be associated with fewer vascular access

evaluated each study for inclusion criteria and extracted outcome data

complications.4

in duplicate using Μicrosoft Excel. Discrepancies were settled by con-

We performed a meta-analysis of randomized and observational

sensus between authors.

studies comparing radial and femoral access for coronary procedures
in prior CABG patients.

2.3
2

Bias assessment

The Newcastle-Ottawa Scale7 was used for observational studies, and

METHODS

|

|

the Cochrane Risk of Bias tool8 (second version) was used for ranWe performed the meta-analysis according to the PRISMA (preferred
5

reporting items for systematic reviews and meta-analyses) and pro-

domized studies. Publication bias was assessed using the visual examination of the funnel plot and Egger's test.9

posal for conducting and reporting meta-analyses of observational
studies (MOOSE) guidelines.6 The search strategy is described in
Figure 1A. Our search was limited to the English language.

2.4

|

Statistical analysis

Categorical variables are presented as percentages and continuous

2.1

|

Study selection

variables are summarized by mean ± SD or median (interquartile
range). For the frequentist analysis: for binary outcomes, the odds

We included both randomized and observational studies comparing

ratio (OR) with 95% confidence interval (CI) was calculated for each

radial access with femoral access for coronary angiography (CA) and/

study using the DerSimonian and Laird random-effects model. For

or percutaneous coronary intervention (PCI) in patients with previous

continuous outcomes, the effect size was the mean difference (MD),

CABG, in which at least one of the following outcomes was reported:

and was calculated using the random effects inverse variance method.

(1) access-site complications, (2) crossover rate to a different vascular

The I2 statistic was used to quantify heterogeneity.10 Meta-regression

access, (3) procedure time, and (4) contrast volume.

analysis was performed due to the presence of moderate to high

FIGURE 1

(A) Search strategy used. (B) Study flow diagram

2020

2013

65.7 ± 6.3

128 (100)

30.95
± 5.45

54 (42)

40 (31.2)

Year

Age (years,
mean
± SD)

Men (n, %)

BMI (kg/m2,
mean
± SD)

PCI (n, %)

Acute
coronary
syndrome
(n, %)

Yes

Yes

2.25 ± 0.95

N/A

Arterial graft
(yes/no)

Number of
grafts
(mean
± SD)

GP IIb/IIIa
inhibitors
(n, %)

N/A

2.4 ± 0.9

N/A

Sheath size >7 N/A
Fr (n, %)

78 (52.3)

48 (32.2)

30.6 ± 4.5

135 (90.6)

70.7 ± 9.5

Tsigkas
et al.
(N = 150)3

Randomized studies

Yes

4 (21.05)

19 (100)

18 (94.7)

26.6 ± 2.8

16 (84.2)

70.3 ± 10.4

2012

5/52 (9.6)

15 (78.95)

1.9 ± 1.21 2 ± 1

0 (0)

N/A

66 (68%)

97 (100)

32.6
± 9.06

0 (0)

65.4 ±
11.54

2014

Rao et al.
(N = 97)12

Romagnoli
et al.
(N = 19)13

N/A

2.75

N/A

N/A

275 (47.1)

190 (32.6)

37.14

0 (0)

64.77
± 11.45

2020

N/A

N/A

Yes

0 (0)

N/A

N/A

28.56
± 4.22

333 (75.4)

67.56
± 8.99

2018

Balaban
Amro et al. et al.
14
(N = 442)15
(N = 584)

Observational studies

2008

Burzotta
et al.
(N = 60)17

54 (90)

116 (38.02)

N/A

No

42 (13.7)

60.98

305 (100)

N/A

2.3 ± 0.63

yes

0 (0)

16 (26.6)

47 (78)

28.32 ± 0.59 N/A

260 (83.8)

69.33 ± 0.80 65 ± 7.91

2012

Bundhoo
et al.
(N = 305)16

Characteristics of the studies included in the analysis

Michael
Study
et al.
characteristics (N = 128)2

TABLE 1

2015

674 (68.4)

64.49 ± 10

29 (15.7)

N/A

yes

32 (17.3)

104 (56.5)

184 (100)

N/A

N/A

N/A

N/A

N/A

N/A

23.99 ± 1.8 30.53
± 6.53

135 (73.3)

62 ± 8.17

2018

24 (19.3)

N/A

Yes

N/A

96 (77.4)

54 (43.5)

26 ± 2.59

96 (77.4)

64.54
± 8.08

2012

N/A

N/A

2111 (98)

1060 (49.2)

30.22 ± 6.08

1568 (72.8)

66.19
± 10.26

2019

15 (0.04)

N/A

2.51 ± 0.82 2.92 ± 1.01
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31 (0.08)

273 (67.5)

404 (100)
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Duarte
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N/A
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N/A

N/A
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N/A

N/A

N/A

2019

2040 (10.6)
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N/A

N/A

9554 (49.7)

19,199 (100)

28.57 ± 4.73

15,998 (83.3)
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2018
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N/A

N/A

N/A

N/A

N/A

N/A
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2009

N/A

3.07

Yes

0 (0)

215 (65.9)

N/A

29 ± 0.47

266 (81.5)

74 (64.3)

N/A

No

28 (24.3)

75 (65.2)

115 (100)

N/A

102 (88.7)

70.22 ± 0.7 63.88
± 10.56

2016

Khan
Pasley
Rathore
et al.
Israeli et al.
Januszek et al. et al.
Kinnaird et al. Orlev et al. et al.
23
24
25
26
27
28
(N = 98)
(N = 326)
(N = 115)29
(N = 1481)
(N = 32,225)
(N = 19,199)
(N = 471)

13 (0.03)

N/A

Yes

0 (0)

97 (31.9)

43 (14)

N/A

258 (84.8)

64.49

2006

Sanmartin
et al.
(Ν = 304)30

103 (33.7)

N/A

No

93 (30.5)

224 (73.6)

334 (100)

N/A

283 (84.7)

69.79
± 9.26

2005

Ziakas
et al.
(N = 334)31
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F I G U R E 2 Methodological
risk of bias assessment for (A) The
randomized studies and (B) the
observational studies included in
the meta-analysis [Color figure
can be viewed at
wileyonlinelibrary.com]

heterogeneity for all endpoints, and because more than 10 studies

data are under the alternative hypothesis (H1-presence of an effect)

were available, in order to explore if the heterogeneity could be attrib-

than under the null hypothesis (H0-no effect); as well as the Bayes

uted to study-level differences.

Factor01 (BF01), which represents how many times more likely the

For the Bayesian analysis, a random effects Bayesian meta-

data are under the null hypothesis than under the alternative hypoth-

analysis was performed using: (a) a weakly informative Cauchy

esis. We interpreted the Bayes Factors using the Jeffreys' evidence

(0, 0.707) prior distribution for the effect size (logOR or mean differ-

categories.11 We finally performed a sequential analysis, displaying

1–4

ence) for all endpoints based on previous studies

and clinical

the development of the BF10 as a function of the number of studies

knowledge and (b) an inverse-gamma (1, 0.15) prior for between-

included in the meta-analysis, with the studies arranged in chronologi-

study heterogeneity for endpoints with low τ in the frequentist

cal order, from oldest to most recent.

2

analysis (crossover rate and vascular access complications) and an

Frequentist statistical analysis was conducted using the Review

inverse-gamma (1, 5) for the endpoints of procedure time and contrast

Manager software (Version 5.4.1. Copenhagen: The Nordic Cochrane

volume, for which we found high τ2 during the frequentist

Centre, The Cochrane Collaboration, 2014). The frequentist meta-

meta-analysis. The mean and 95% credible interval (CrI) of each poste-

regression analysis was performed using the R (R core team, R Foun-

rior distribution were calculated. We also calculated the Bayes

dation for Statistical Computing, Vienna, Austria) metaphor and stats

Factor10 (BF10), which represents how many times more likely the

packages with the use of the JASP software (Version 0.13.1, JASP

5
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F I G U R E 3 Publication bias for the endpoint of (A) vascular access complications, (B) crossover rate to a different vascular access,
(C) procedure time, and (D) contrast volume

Team, University of Amsterdam, Netherlands). The Bayesian analysis

studies. Sixteen studies included patients with acute coronary syn-

was conducted with the R metaBMA package, with the use of the

dromes. The characteristics of each study are summarized in

JASP software.

Table 1.

3

3.2

3.1

RESULTS

|
|

Search results and study characteristics

|

Bias assessment

All randomized studies were at low risk of bias (Figure 2A). Most
observational studies scored 7 stars in the Newcastle-Ottawa scale

Twenty-two of the 767 studies identified in the literature search

(Figure 2B), with nine being the maximum number of stars, and more

were included in the analysis (Figure 1B). Four studies were ran-

stars meaning less risk of bias.

domized and 18 were observational. The total number of patients

Publication bias, as judged by visual inspection of the funnel plot

was 60,192 (27,236 in the radial group; 32,956 in the femoral

and Egger's test, was absent for procedure time and contrast volume

group). Most patients (71%) were men. Eight studies included only

but present for vascular access complications and crossover rates

PCI procedures. Patients with arterial grafts were included in nine

(Figure 3).

6
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F I G U R E 4 Meta-analysis of (A) vascular access complications and (B) crossover to a different vascular access. The forest plot graphs the odds
ratio for vascular access complication/crossover rates between the radial approach and the femoral approach [Color figure can be viewed at
wileyonlinelibrary.com]

F I G U R E 5 Meta-analysis of (A) procedure time and (B) contrast volume. The forest plot graphs the mean difference in procedure time
(expressed in minutes)/contrast volume (expressed in milliliters) between the radial approach and the femoral approach [Color figure can be
viewed at wileyonlinelibrary.com]

3.3

|

Frequentist meta-analysis

group (OR: 5.09; 95% CI: 2.43, 10.65; p < 0.001) (Figure 4B), while
procedure time (MD: 1.95; 95% CI:

Among randomized studies, crossover rates were higher with radial

0.23, 4.14; p = 0.08) (Figure 5A)

was similar between the two groups.

access (OR: 7.63; 95% CI: 2.04, 28.51; p = 0.003) (Figure 4B), while
vascular access complication rates (OR: 0.96; 95% CI: 0.34, 2.87;
p = 0.94) (Figure 4A), procedure time (MD: 5.76; 95% CI:

4.38,

3.4

|

Heterogeneity and meta-regression analysis

15.89; p = 0.27) (Figure 5A) and contrast volume (MD: 15.08; 95% CI:
10.19, 40.35; p = 0.24) (Figure 5B) were similar.

In randomized studies, there was no between-study heterogeneity

In observational studies, vascular access complication rates (OR:

for the endpoints of vascular access complications and crossover

0.52; 95% CI: 0.30, 0.89; p = 0.02) (Figure 4A) and contrast volume

rate (I2 = 0), but there was high heterogeneity for contrast volume

1.90; p = 0.009) (Figure 5B) were

(I2 = 71%) and procedure time (I2 = 91%). In observational studies,

lower in the radial group. Crossover rates were higher in the radial

there was high heterogeneity for vascular access complications

(MD: -7.52; 95% CI:

13.14,

NIKOLAKOPOULOS ET AL.

7

F I G U R E 6 Meta-regression analysis of (A) vascular access complications rates, (B) crossover rates to a different vascular access, (C) procedure
time, and (D) contrast volume

F I G U R E 7 Bayesian random effects meta-analysis of (A) vascular access complications rates, (B) crossover rates to a different vascular access,
(C) procedure time, and (D) contrast volume [Color figure can be viewed at wileyonlinelibrary.com]

(I2 = 71%), contrast volume (I2 = 83%), and procedure time

None of the parameters included in the meta-regression analysis was

(I2 = 72%), and moderate heterogeneity for crossover rate (I2 = 45%).

significantly associated with any of the four endpoints, and there was

8
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F I G U R E 8 Sequential analysis of Bayes factors for the endpoints of (A) vascular access complications rates, (B) crossover rates to a different
vascular access, (C) procedure time, and (D) contrast volume [Color figure can be viewed at wileyonlinelibrary.com]

significant residual heterogeneity in the endpoints of procedure time

4

|

DI SCU SSION

and contrast volume (Figure 6).
The main findings of our study were that: (a) most data on radial versus femoral access in patients with prior bypass surgery are observa-

3.5

|

Bayesian meta-analysis

tional, (b) crossover rate in prior CABG patients is higher with radial
access in both observational and randomized studies, and (c) vascular

The evidence of a difference existing between radial and femoral access

access complications and contrast volume are lower with radial access

was anecdotal for the endpoints of access complications (BF10 = 0.624;

in observational studies but not in RCTs. Taken together, our findings

mean: 0.093; 95% CrI:

suggest possible attenuated benefits of radial access in patients with

1.231, 1.5) (Figure 7A), procedure time (BF10

= 1.095; mean: 0.815; 95% CrI:

0.816, 3.015) (Figure 7C) and contrast

volume (BF10 = 1.257; mean: -1.736; 95% CrI:

prior CABG patients and increased likelihood of access site crossover.

8.939, 1.688)

The RADIAL versus Femoral Access for Coronary Artery Bypass

(Figure 7D), but was extreme for the endpoint of crossover to another vas-

Graft Angiography and Intervention (RADIAL-CABG) trial randomized

cular access (BF10 = 468; mean: 1.259; 95% CrI: 0.572, 2.148) (Figure 7B).

128 patients with prior CABG to radial or femoral access and showed

On sequential analysis, the strength of the evidence of a differ-

greater contrast use, longer procedure time and greater crossover

ence between radial and femoral access increased over time for cross-

rates with radial access.2 The Left Radial Compared to Femoral

over rate (Figure 8B) and has remained anecdotal to moderate for

Approach for Coronary Angiography in Patients with Previous CABG

access complication rate (Figure 8A) and anecdotal for procedure time

(L-RECORD) study3 randomized 150 patients and demonstrated non-

(Figure 8C) and contrast volume (Figure 8D).

inferiority of radial to femoral for all aforementioned endpoints. Both

9
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studies were single-center, and thus subject to bias arising from oper-

except crossover rate, which can however be a biased endpoint due

ators' experience, as was the case with the RADIAL-CABG study

to different subjective thresholds to cross over from radial to femoral.

where a “fellow first” strategy was adopted. Observational data from
a previous meta-analysis including eight studies found lower access-
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site complication and higher crossover rates with radial access, with
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C O N CL U S I O N S

In a frequentist and Bayesian meta-analysis of patients with prior
CABG undergoing coronary catheterization, radial access was associated with lower incidence of vascular access complications and lower
contrast volume but also higher crossover rate. The odds of a difference existing between radial and femoral is small for all endpoints
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